Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
PLoS Neglected Tropical Diseases(3)
Acta Tropica(1)
Antimicrobial Agents and Chemotherapy(1)
Frontiers in Cellular and Infection Microbiology(1)
Journal of Medical Entomology(1)
Área temáticas
Enfermedades(6)
Medicina forense; incidencia de enfermedades(3)
Microorganismos, hongos y algas(3)
Farmacología y terapéutica(2)
Anatomía humana, citología, histología(1)
Origen
google(1)
Chagas disease control-surveillance in the americas: The multinational initiatives and the practical impossibility of interrupting vector-borne trypanosoma cruzi transmission
ArticleAbstract: Chagas disease (CD) still imposes a heavy burden on most Latin American countries. Vector-borne andPalabras claves:Chagas disease, control, Interruption of transmission, Multinational initiatives, SurveillanceAutores:Fernando Abad-Franch, Guhl F., Monroy C., Rojas-De-Arias A., Santos W.S., Sosa-Estani S.Fuentes:scopusAnalytical validation of quantitative real-time PCR methods for quantification of trypanosoma cruzi DNA in blood samples from chagas disease patients
ArticleAbstract: An international study was performed by 26 experienced PCR laboratories from 14 countries to assessPalabras claves:Autores:Alberti A., Alvarez-Martínez M., Aznar C., Bisio M., Crisante G.E., Cruz-Robles D., Cura C.I., Da Câmara A.C.J., Da Cruz Moreira O., de Noya B.A., De Paoli de Carvalho Britto C.F., Diosque P., Espinoza B., Flores-Chávez M.D., Greif G., Guhl F., Jaime Alfredo Costales, Juiz N., Marcet P.L., Marcos Da Matta Guedes P., Maria Da Cunha Galvão L., Martínez N.E., Muñoz-Calderón A., Padilla C., Parrado R., Pavia P., Peneau J., Pérez-Morales D., Puerta C., Ramírez J.C., Ramírez J.D., Riarte A., Ribeiro I., Sánchez Z., Santalla J., Schijman A.G., Silva E.L., Sosa-Estani S., Valencia E., Velázquez E., Villarroel R., Villarroel S., Yadón Z.E., Zulantay I.Fuentes:scopusDevelopment of Peptide-Based Lineage-Specific Serology for Chronic Chagas Disease: Geographical and Clinical Distribution of Epitope Recognition
ArticleAbstract: Background:Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a serioPalabras claves:Autores:Bhattacharyya T., Carrasco H.J., Diosque P., Falconar A.K.I., García L., Guhl F., Jaime Alfredo Costales, Lewis M.D., Litvinov S.V., Luquetti A.O., Mario J. Grijalva, Messenger L.A., Miles M.A., Ramírez J.D., Tran T.T.Fuentes:scopusMetric variation among geographic populations of the chagas vector Triatoma dimidiata (Hemiptera: Reduviidae: Triatominae) and related species
ArticleAbstract: Eight Triatoma dimidiata populations from different geographic regions were compared along with relaPalabras claves:Interspecific differences, intraspecific variation, Traditional morphometry, Triatoma dimidiataAutores:Bustamante D.M., Guhl F., Jean Pierre Al Dujardin, Menes M., Monroy C., Pinto N., Rodas A., Rojas G., Salazar-Schettino P.M.Fuentes:scopusPhylogeography and genetic variation of Triatoma dimidiata, the main chagas disease vector in Central America, and its position within the genus Triatoma
ArticleAbstract: Background: Among Chagas disease triatomine vectors, the largest genus. Triatoma, includes species oPalabras claves:Autores:Bargues M.D., Fernando Abad-Franch, Gonzalez-Candelas F., Guhl F., Jean Pierre Al Dujardin, Klisiowicz D.R., Mas-Coma S., Monroy C., Panzera P., Ponce C., Ramsey J.M., Salazar-Schettino P.M., Schofield C.J., Sousa O.E.Fuentes:scopusTowards a paradigm shift in the treatment of chronic chagas disease
ReviewAbstract: Treatment for Chagas disease with currently available medications is recommended universally only foPalabras claves:Autores:Araujo-Jorge T., de Noya B.A., Gascón J., Guhl F., López M.C., Mario J. Grijalva, Ramsey J.M., Ribeiro I., Schijman A.G., Sosa-Estani S., Torrico F., Viotti R.Fuentes:scopusSerological reactivity against T. cruzi-derived antigens: Evaluation of their suitability for the assessment of response to treatment in chronic Chagas disease.
ArticleAbstract: Chagas disease, caused by the protozoan Trypanosoma cruzi, affects more than 6 million people worldwPalabras claves:3973, antigens, Chagas disease, Chemotherapy response, Chronic infection, F29, hsp70, InfYnity multiplexed ELISA, KMP11, PFR2, TRYPANOSOMA CRUZIAutores:Abril M., Alonso-Padillaid J., Benítez C., Casellas A., Chatelain E., de Noya B.A., Esteva M., Gascón J., Gómez I., Granjon E., Guhl F., Hasslochermoreno A.M., Jorge T.A., Longhi S.A., López M.C., Luquetti A.O., Mario J. Grijalva, Méndez S., Noya O., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Sanz S., Schijman A.G., Sosa-Estani S., Thomas M.C., Torrico F., Viotti R., Zrein M.Fuentes:scopusRepeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi
ArticleAbstract: Trypanosoma cruzi, a zoonotic kinetoplastid protozoan parasite, is the causative agent of American tPalabras claves:antigenic variation, Genome sequence, microbial genomics, Parasitology, pathology of infectious diseases, Population genetics, tropical medicine, TRYPANOSOMA CRUZIAutores:Andersson B., Bartholomeu D.C., Bottazzi M.E., Burleigh B.A., Calzada J.E., Carrasco H.J., Gorchakov R., Grisard E.C., Guhl F., Hotez P.J., Jaime Alfredo Costales, Jones K., Lewis M.D., Mario J. Grijalva, Matos G.M., Messenger L.A., Miles M.A., Murray K.O., Nolan M.S., Ramírez J.D., Reis-Cunha J.L., Saldaña A., Sofia Ocana-Mayorga, Talavera-López C., Teixeira S.M.R., Yeo M.Fuentes:googlescopusTarget product profile for a test for the early assessment of treatment efficacy in chagas disease patients: An expert consensus
ArticleAbstract:Palabras claves:Autores:Abril M., Almeida I.C., Alonso-Padillaid J., Angheben A., Carmen Thomas M., Chatelain E., de Noya B.A., Esteva M., Gascón J., Guhl F., Hasslochermoreno A.M., Jorge T.A., López M.C., Luquetti A.O., Mario J. Grijalva, Noya O., Picado A., Pinazo M.J., Ramsey J.M., Ribeiro I., Ruiz A.M., Schijman A.G., Sosa-Estani S., Torrico F., Zreinid M.Fuentes:scopus